Youssef Aziz

Youssef Aziz

Associate

Youssef advises issuers and investment banks on a broad range of capital markets transactions, as well as SEC reporting, compliance and corporate governance matters.
Youssef’s practice includes a wide array of securities offerings, including investment grade and high-yield debt offerings, initial public offerings, follow-on equity offerings and private placements, as well as other financing transactions. He also advises public companies and institutional investors on SEC reporting, securities law and stock exchange compliance and corporate governance matters.
 
Youssef works with companies across a variety of industries, including financial services, technology, healthcare and industrials.

Expertise

Industries

Experience

Representative matters

Relevant previous firm experience:

  • BofA Securities, Inc., Citigroup Global Markets Inc., Wells Fargo Securities, LLC and Goldman Sachs & Co. LLC, as joint book-running managers, in connection with the $600 million notes offering by Mattel, Inc. (Nasdaq: MAT).
  • J.P. Morgan, as representative of the initial purchasers, in connection with a Rule 144A / Reg S offering of $600 million senior secured notes by Amneal Pharmaceuticals LLC, a subsidiary of Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX).
  • Goldman Sachs, as sole book-running manager, in connection with the $550 million junior subordinated notes offering by Dentsply Sirona (Nasdaq: XRAY).
  • Morgan Stanley, Goldman Sachs, HSBC, Wells Fargo Securities, and the other initial purchasers, in connection with the $1.25 billion offering of senior notes by Helmerich & Payne, Inc. (NYSE: HP).
  • The underwriters in connection with various registered offerings of senior notes by American Homes 4 Rent (NYSE: AMH).
  • The sales agents, forward sellers and forward purchasers in connection with the $1.0 billion at-the-market offering by American Homes 4 Rent (NYSE: AMH).
  • Goldman Sachs, J.P. Morgan, Jefferies, Morgan Stanley, William Blair, and Guggenheim Securities, as the underwriters, in connection with the $329 million underwritten public offering of ordinary shares by SharkNinja, Inc. (NYSE: SN).
  • Morgan Stanley and Huatai Securities, as the underwriters, in connection with the $52.7 million initial public offering of american depositary shares by Super Hi International Holding Ltd. (Nasdaq: HDL).
  • FACT II Acquisition Corp. (Nasdaq: FACT), a special purpose acquisition company, in connection with its $175 million initial public offering.
  • Kyverna Therapeutics, Inc. (Nasdaq: KYTX) in connection with its $367 initial public offering.
  • Jasper Therapeutics, Inc. (Nasdaq: JSPR) in its $103.5 million follow-on public offering of shares of common stock.
  • Alpha Teknova, Inc. (Nasdaq: TKNO) in its $15.4 million private placement offering of shares of common stock.
  • Altisource Portfolio Solutions S.A. (Nasdaq: ASPS) in a set of liability management transactions, including the exchange of its existing $232.8 million term loans for $160 million in new first-lien term loans with an extended maturity and 58.2 million common shares.
  • Paige.AI, an artificial intellence company specializing in digital pathology, in connection with its $81.25 million acquisition by Tempus AI, Inc. (Nasdaq: TEM).
  • FiscalNote Holdings, Inc. (NYSE: NOTE) in connection with its $1.3 billion business combination and go-public transaction with Duddell Street Acquisition Corp.
  • Freedom Acquisition I Corp. in its business combination with SunPower Inc. (Nasdaq: SPWR).

Qualifications

Admissions

Attorney-at-law, State of New York, US, 2023

Lawyer, Province of Ontario, Canada, 2020

Academic

J.D., University of Toronto, 2019

Honours BBA, Wilfrid Laurier University, 2015

Languages

Arabic
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.